Contact Us

ReNu Contact Solution
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Parker Waichman LLP Files Suit Against Bausch & Lomb, Inc. on Behalf of Man Diagnosed with Fusarium Keratitis After Using Renu with MoistureLoc®

Jul 2, 2007 | Prime Newswire

Parker Waichman LLP announces that it has filed suit on behalf of a man diagnosed with Fusarium Keratitis in his right eye after using Renu with MoistureLoc® Contact Lens Solution.  As a result of the infection, the man continues to suffer from a significant loss of vision.  The suit was filed in the Supreme Court of the State of New York, New York County.

If you or a loved one believe that you were injured as a result of using Bausch & Lomb’s ReNu with MoistureLoc® Contact Lens Solution, please contact our office by visiting   Free case evaluations are also available by calling 1-800-YOURLAWYER (1-800-968-7529).

In October 2005, the injured man, a resident of Georgia, was diagnosed with injuries to his right eye including fungal keratitis, a corneal ulcer, epithelial defect, corneal edema and corneal perforation, all of which required extensive medical treatment.  In November 2005, his right eye tested positive for Fusarium.  As a result of these injuries, the victim now suffers from a significant and permanent loss of vision.

On April 10, 2006, the FDA and the CDC issued public health warnings concerning serious fungal infections associated with contact lens solution use. The CDC stated that it had interviewed 30 patients suspected of having fungal keratitis. Of these 30 patients, 28 wore soft contact lenses and 26 used a Bausch & Lomb ReNu contact lens solution in the month prior to the fungal infection diagnosis. On April 13, 2006, Bausch & Lomb, Inc. recommended that consumers switch to another lens care solution and asked all retailers to remove U.S. manufactured ReNu with MoistureLoc®  from their shelves. On May 2, 2006 the CDC announced that the number of confirmed fungal infections rose to 88 cases.  Just three days later, on May 5, 2006, the CDC revised the number of confirmed cases to 102.

On May 12, 2006, the CDC made another upward revision in the number of confirmed fungal eye infections to 122 cases. On May 15, 2006, the FDA issued a press release stating: “Based on this scientific and epidemiological data suggesting that ReNu with MoistureLoc may increase susceptibility to Fusarium, Bausch & Lomb has decided to permanently remove the ReNu with MoistureLoc product worldwide.’’  The recall followed Bausch & Lomb’s conclusion that the product’s formula may increase the risk of fungal eye infections in certain situations.  Bausch & Lomb, Inc. and the FDA both acknowledged there is a problem in the chemical properties of ReNu with MoistureLoc® after testing confirmed that the solution allows a polymer film to form around the Fusarium fungus preventing the disinfectant in the product from killing the fungus.

Fungal keratitis is a severe infection of the cornea.  Risk factors for infection usually include trauma (generally with plant material), chronic ocular surface diseases, immunodeficiencies, and, rarely, contact lens use.  An estimated 30 million people in the United States wear soft contact lenses; the annual incidence of microbial keratitis is estimated to be 4 - 21 per 10,000 soft contact lens users.  Fungal keratitis is a condition more prevalent in warm climates.  First-line treatment includes topical and oral antifungal medications.  Patients who do not respond to treatment usually require surgical intervention, including corneal transplantation. These infections are not transmitted from person to person.

About Parker Waichman LLP:  

Parker Waichman LLP is leading the litigation against Bausch & Lomb, Inc. on behalf of people injured as a result of using ReNu with MoistureLoc® Contact Lens Solution.  Parker Waichman LLP has also filed a medical monitoring class-action suit against Bausch & Lomb, Inc. seeking compensation for medical evaluations for all people who used ReNu with MoistureLoc. 
Parker Waichman LLP is a leading products liability and personal injury law firm that represents plaintiffs nationwide.  The firm has offices in New York and New Jersey.  Parker Waichman LLP has assisted thousands of clients in receiving fair compensation for injuries resulting from defective products, medications and medical devices.

For more information on Parker Waichman LLP, please visit: or call 1-800-YOURLAWYER (1-800-968-7529).

CONTACT:    Parker Waichman LLP
                  (800) YOURLAWYER
                  (800) 968-7529


Related articles Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo